Tag: Heart Failure
Women at Increased Risk for Heart Failure, Death After MI
Women had higher unadjusted rate of in-hospital mortality than men after first-time STEMI, NSTEMI
AHA: Sotagliflozin Beneficial for T2DM With Heart Failure
Second study shows benefits among patients with type 2 diabetes and chronic kidney disease, risks for CVD
Risk for Heart Failure Lower With Healthy Sleep Patterns
Hazard ratio 0.58 for heart failure with healthy sleep score of 5 versus score of 0 or 1
Polypharmacy Common in Seniors With Heart Failure
With increasing number of medications, more rapid increase seen in number of noncardiovascular meds
Outcomes Worse for Deferred Aortic Valve Replacement
Mortality, stroke, hospitalization seen in 19.1 and 4.0 percent with deferred versus expedited AVR
Hydroxychloroquine Tied to Heart Problems Prior to Pandemic
Adverse outcomes include cardiomyopathy, QT prolongation, cardiac arrhythmias, heart failure
Rates of Recurrent MI Declined Among U.S. Women and Men
Decreases seen in rates of recurrent MI, recurrent CHD events, heart failure hospitalization
Severely Obese Heart Donors Not Tied to Adverse Transplant Outcomes
Short-term outcomes for recipients similar for heart transplants from donors with, without severe obesity
Rates of Ambulatory Heart Failure Steady From 2001 to 2016
Greatest disparities seen between Black and White adults aged 35 to 64 years
Empagliflozin Superior to Placebo for Heart Failure
Risk for CV death, hospitalization with heart failure reduced, regardless of presence of diabetes
